WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Results of Operations and Financial Condition

WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02 Results of Operations and Financial Condition.

On April 27, 2017, West Pharmaceutical Services, Inc. (the
Company) issued a press release announcing its first-quarter 2017
financial results. A copy of the press release is attached hereto
as Exhibit 99.1 and incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
The information set forth in Item 2.02 Results of Operations and
Financial Condition, including the exhibit referred to therein,
is incorporated herein by reference.
A copy of the Companys presentation materials used during the
call will be available through the Investors link at the Companys
website, http://www.westpharma.com,>and is also attached
hereto as Exhibit 99.2 and incorporated herein by reference.
The information in this report (including the exhibits attached
hereto) is being furnished to Item 2.02 and Item 7.01 and shall
not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (Exchange Act), or otherwise
subject to the liabilities of that section, nor will it be
incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act, except as expressly set
forth by specific referencing in such filing.
Item 9.01 Financial Statements and Exhibits.
Exhibit No.
West Pharmaceutical Services, Inc. Press Release, dated
April 27, 2017.
West Pharmaceutical Services, Inc. Presentation Slides.


West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.


WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) closed its last trading session 00.00 at 84.00 with 626,313 shares trading hands.

An ad to help with our costs